Examination of the Novel Sigma-1 Receptor Antagonist, SI 1/28, for Antinociceptive and Anti-allodynic Efficacy against Multiple Types of Nociception with Fewer Liabilities of Use

por Wilson, Lisa L., Eans, Shainnel O., Ramadan-Siraj, Insitar, Modica, Maria N., Romeo, Giuseppe, Intagliata, Sebastiano, McLaughlin, Jay P.
Publicado 2022